These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat. Alvarez-Guerra M, Alda O, Garay RP. Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952 [Abstract] [Full Text] [Related]
6. Effects of the R(+)- and S(-)-isomers of beta-adrenoceptor blockers with intrinsic sympathomimetic activity, befunolol and carteolol, on rabbit intraocular pressure. Takayanagi I, Hagiwara H, Koike K, Hosokawa T, Kasuya Y. Can J Physiol Pharmacol; 1991 Aug; 69(8):1243-5. PubMed ID: 1685941 [Abstract] [Full Text] [Related]
8. Comparison of interactions of R(+)- and S(-)-isomers of beta-adrenergic partial agonists, befunolol and carteolol, with high affinity site of beta-adrenoceptors in the microsomal fractions from guinea-pig ciliary body, right atria and trachea. Koike K, Horinouchi T, Takayanagi I. Gen Pharmacol; 1994 Nov; 25(7):1477-81. PubMed ID: 7896063 [Abstract] [Full Text] [Related]
10. Thermodynamic analysis of beta-adrenergic partial agonists (befunolol and carteolol) interaction with low and high affinity binding sites of beta-adrenoceptors in guinea-pig taenia caecum. Takayanagi I, Ogishima M, Koike K. Gen Pharmacol; 1990 Nov; 21(3):303-7. PubMed ID: 1971246 [Abstract] [Full Text] [Related]
11. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors. Reithmann C, Wieland F, Jakobs KH, Werdan K. Eur J Pharmacol; 1989 Nov 07; 170(3):243-55. PubMed ID: 2575997 [Abstract] [Full Text] [Related]
12. Comparison of interactions of R-(+)- and S-(-)-isomers of beta-adrenergic partial agonists, befunolol and carteolol, with high affinity site of beta-adrenoceptors in isolated rabbit ciliary body and guinea-pig taenia caeci. Koike K, Hagiwara H, Takayanagi I. Can J Physiol Pharmacol; 1991 Jul 07; 69(7):951-7. PubMed ID: 1683268 [Abstract] [Full Text] [Related]
14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ. J Pharmacol Exp Ther; 1987 Sep 07; 242(3):1025-34. PubMed ID: 2888869 [Abstract] [Full Text] [Related]
15. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated? Jakubetz J, Schmuck S, Poller U, Fuchs B, Gorf A, Radke J, Pönicke K, Brodde OE. J Cardiovasc Pharmacol; 1999 Mar 07; 33(3):461-72. PubMed ID: 10069683 [Abstract] [Full Text] [Related]
16. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol. Leff AR, Garrity ER, Munoz NM, Tallet J, Cavigelli M, Deitchman D, Rajfer SI. J Cardiovasc Pharmacol; 1984 Mar 07; 6(5):859-66. PubMed ID: 6209492 [Abstract] [Full Text] [Related]
17. Blockade of isoprenaline-induced fluid and protein secretion by the mandibular glands of the red kangaroo, Macropus rufus, with selective antagonists. Beal AM. Arch Oral Biol; 2000 Aug 07; 45(8):701-6. PubMed ID: 10869482 [Abstract] [Full Text] [Related]